Filomena De Falco

Perugia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Rab GTPases drive ligand-independent NOTCH1 activation via altered endocytic trafficking in chronic lymphocytic leukemia.

Journal: HemaSphere

Published: August 18, 2025

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Bcor loss promotes Richter transformation of chronic lymphocytic leukemia associated with Notch1 activation in mice.

Journal: Leukemia

Published: August 22, 2024

Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.

Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies.

Journal: International journal of molecular sciences

Published: July 17, 2024

Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia.

Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia.

Journal: Cancers

Published: March 30, 2024

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia.

Journal: Cancers

Published: May 26, 2023

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

Journal: EJHaem

Published: May 19, 2023

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

NOTCH1-mutated chronic lymphocytic leukemia displays high endoplasmic reticulum stress response with druggable potential.

Journal: Frontiers in oncology

Published: May 10, 2023

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.

Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study.

Journal: Cancers

Published: April 13, 2023

A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect.

A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect.

Journal: Leukemia

Published: January 21, 2023

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia.

Journal: British journal of haematology

Published: September 29, 2022

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

GSK3β is a critical, druggable component of the network regulating the active NOTCH1 protein and cell viability in CLL.

Journal: Cell death & disease

Published: January 17, 2022

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.

Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia.

Journal: Frontiers in oncology

Published: June 22, 2021

Showing 1-12 of 24

Last Updated: 09/26/2026